Seton Hall University

eRepository @ Seton Hall
Seton Hall University Dissertations and Theses
(ETDs)

Seton Hall University Dissertations and Theses

Spring 5-17-2014

The Use of Natural Products as Potential AntiPseudomonas Agents
Margaret B. Bell
margaret.bell@student.shu.edu

Follow this and additional works at: https://scholarship.shu.edu/dissertations
Part of the Alternative and Complementary Medicine Commons, and the Microbiology
Commons
Recommended Citation
Bell, Margaret B., "The Use of Natural Products as Potential Anti-Pseudomonas Agents" (2014). Seton Hall University Dissertations and
Theses (ETDs). 1983.
https://scholarship.shu.edu/dissertations/1983

THE USE OF NATURAL PRODUCTS AS POTENTIAL
ANTI-PSEUDOMONAS AGENTS

By
MARGARET B. BELL

Submitted in partial fulfillment of the requirements for the
degree of Master of Science in Microbiology from the
Department of Biological Sciences of Seton Hall University
May 2014

APPROVED BY

_______________________________________
MENTOR
Dr. Tin-Chun Chu

_______________________________________
COMMITTEE MEMBER
Dr. Angela Klaus

_______________________________________
COMMITTEE MEMBER
Dr. Sylvia Rabacchi

_______________________________________
DIRECTOR OF GRADUATE STUDIES
Dr. Allan Blake

_______________________________________
CHAIRPERSON, DEPARTMENT OF BIOLOGICAL SCIENCES
Dr. Jane Ko

ACKNOWLEDGMENTS
I would like to express my deepest gratitude to the following individuals for their support and
assistance:
Dr. Tin-Chun Chu, for all of her help over the past two years. From the beginning, you helped
direct me in a path that will help me for the rest of my life. You helped me develop the
techniques and mindset that I needed to succeed. You have also been my number one supporter
when others omitted me. Thank you for being such a inspirational person in my life.
Dr. Angela Klaus, for her time and consideration as a member of my thesis committee so that I
could earn my Master’s degree.
Dr. Sylvia Rabacchi, for her time and consideration as a member of my thesis committee so that
I could earn my Master’s degree.
Dr. Shoshana Arad, for her generous donation of the red microalgae polysaccharide.
Dr. Chih-Yu Lo, for his generous donation of the tea polyphenols and the Chinese Knotweed.
Dr. Chu’s Research Laboratory Graduate Students, my colleagues and classmates: Robert
Newby, Aline deOliveira, Nicole Elia, Derek Prince, and Jose Perez.
Ms. Aline deOliveira, for all of her time and help with the confocal microscope and improving
experimental designs.
The Seton Hall University Department of Biological Sciences faculty, staff, and students. I
would like to thank the faculty and staff for their support and inspirations. I would like to extend
my gratitude to my fellow classmates for their support and encouragement as we embarked on
the graduate school journey alongside one another.
Dr. Alfred Bell and Deborah Bell, my parents, and my sister, Starla A. Bell, for their constant
support. Over the years, you have witnessed me encounter different endeavors and you have
been behind me the entire way. Thank you for always letting me know I had three people in my
corner. Mariah Bell, my niece, for being my inspiration.
My extended family and friends, for their understanding, inspirations, and support. Thank you
from the bottom of my heart.
i

TABLE OF CONTENTS
Abstract

vii

Introduction

1

Materials and Methods

13

Results

18

Conclusion and Discussion

48

Literature Cited

50

ii

LIST OF TABLES
Table 1

Complete list of the natural products used as potential antiPseudomonas agents.

14

Table 2

The antimicrobial effects of natural products on
Pseudomonas.

56

iii

LIST OF FIGURES
Figure 1

Molecular structure of major Theaflavins found in black tea

7

Figure 2

Molecular structure of the polymethoxyflavones nobiletin and
tangeretin

8

Figure 3

Large scale cultivation of red microalgae Porphyridium

8

Figure 4

Proposed structure of the polysaccharide extracted from the
microalgae species Porphyridium

10

Figure 5

Fallopia multiflora root

12

Figure 6

Growth curve of Pseudomonas fluorescens treated with the red
algae polysaccharide

12

Figure 7

Percent inhibition of Pseudomonas fluorescens treated with the
red algae polysaccharide

19

Figure 8

Growth curve of Pseudomonas fluorescens treated with
theaflavin.

19

Figure 9

Percent inhibition of Pseudomonas fluorescens treated with
theaflavin.

21

Figure 10

Growth curve of Pseudomonas aeruginosa treated with
theaflavin.

21

Figure 11

Percent inhibition of Pseudomonas aeruginosa treated with
theaflavin.

23

Figure 12

Growth curve of Pseudomonas fluorescens treated with Chinese
knotweed

23

Figure 13

Percent inhibition of Pseudomonas fluorescens treated with
Chinese knotweed.

25

Figure 14

Growth curve of Pseudomonas fluorescens treated with
nobiletin.

25

Figure 15

Percent inhibition of Pseudomonas fluorescens treated with
nobiletin.

27

Figure 16

Growth curve of Pseudomonas fluorescens treated with
tangeretin

27

iv

Figure 17

Percent inhibition of Pseudomonas fluorescens treated with
tangeretin

29

Figure 18

Growth curve of Pseudomonas fluorescens treated with 5-OH
nobiletin

29

Figure 19

Percent inhibition of Pseudomonas fluorescens treated with 5OH nobiletin

31

Figure 20

Growth curve of Pseudomonas fluorescens treated with 5’OHtangeretin

31

Figure 21

Percent inhibition of Pseudomonas fluorescens treated with
5’OH-tangeretin

33

Figure 22

Percent inhibition of Pseudomonas fluorescens treated with the
seven natural products.

33

Figure 23

Crystal violet staining of Pseudomonas fluorescens biofilm
treated with theaflavin

35

Figure 24

Pseudomonas aeruginosa untreated (A) and treated with 2.5%
theaflavin (B). TM 600X.

38

Figure 25

Pseudomonas aeruginosa untreated (A) and treated with 2.5%
Chinese Knotweed (B). TM 600X

38

Figure 26

Pseudomonas aeruginosa untreated (A) and treated with the
0.5% red microalgae polysaccharide (B). TM 600X

39

Figure 27

Pseudomonas aeruginosa untreated (A) and treated with 500
µM nobiletin (B). TM 600X

39

Figure 28

Pseudomonas aeruginosa untreated (A) and treated with 500
µM tangeretin (B). TM 600X

40

Figure 29

Pseudomonas aeruginosa untreated (A) and treated with 500
µM 5’OH-nobiletin (B). TM 600X

40

Figure 30

Pseudomonas aeruginosa untreated (A) and treated with 500
µM 5’OH-tangeretin (B). TM 600X

41

Figure 31

Crystal violet assay of Pseudomonas fluorescens biofilm treated
with theaflavin.

43

v

Figure 32

Biofilm inhibition of Pseudomonas fluorescens treated with
theaflavin

43

Figure 33

Crystal violet assay of Pseudomonas aeruginosa biofilm treated
with theaflavin.

44

Figure 34

Biofilm inhibition of Pseudomonas aeruginosa treated with
theaflavin.

44

Figure 35

Pseudomonas aeruginosa biofilm formation experimental setup

46

Figure 36

Microscope images of Pseudomonas aeruginosa biofilm

47

vi

Abstract
Pseudomonas is a genus of gram-negative gammaproteobacteria with a large range of diversity.
Because of its ability to grow at low temperature, Pseudomonas is a cause of food spoilage. This
bacterium is also a very common nosocomial infection of hospital patients. In this study, we
investigated the effects of different natural products on Pseudomonas. The products included a
polysaccharide, two flavonoids tangeretin and nobiletin and their derivatives, 5’OH-tangeretin
and 5’OH-nobiletin, black tea polyphenol – theaflavins (TFs), as well as an herb named Fallopia
multiflora (Chinese Knotweed). P. fluorescens and P. aeruginosa were used as model organisms.
Antimicrobial effects were evaluated at various concentrations by using a microtiter plate assay
or culture tube assay. The inhibition of biofilm formation was also determined using crystal
violet assay. The results indicated that the selected natural products have antibacterial effect and
anti-biofilm formation on Pseudomonas. Of the seven compounds studied 2.5% theaflavin, 2.5%
Chinese Knotweed, and 500 µM of tangeretin showed the greatest antimicrobial effect.

vii

Introduction
Pseudomonas is a genus of gram-negative bacteria that is the source of many acute and chronic
infections. The bacteria can be isolated from environmental sources such as freshwater and soil.
Pseudomonas has a unique resistance to many microbicides. This makes these bacteria a problem in its
removal from equipment and surfaces in hospitals (Lavoie et al 2011). Pseudomonas aeruginosa is a
primary concern in healthcare. The bacteria are the major causing agents in immunocompromised
patients (Martin-Espada et al 2013). P. aeruginosa can cause ventilator-associated pneumonia in
intubated patients. Chronic infections are common in patients in intensive care units. These chronic
infections occur in the respiratory tracts of 80% of adults with cystic fibrosis. Chronic Pseudomonas
infection also occurs in heart, middle ears, and para-nasal sinuses (Alhede et al 2014).

The Pseudomonas genus is a very common source of food spoilage after harvest. The bacteria are so
harmful because they can infect almost all types of vegetables. The bacteria can enter the plant tissue
after mechanical injuries or the barrier being broken by other organisms. The contamination rate is very
high in vegetables due to frequent contact with the soil during the growing process. The high infection
rate of food after harvest not only causes an economic loss, but can be very harmful to humans.
Pseudomonas infections can be seen in cabbage, lettuce, beans, tomatoes, and soybeans (Tournas 2005).

The water systems act as a source of P. aeruginosa infection in healthcare. Although the direct mode of
transmission is unclear, the correlation between P. aeruginosa and the water system is strong. Compared
to other waterborne pathogens, P. aeruginosa excels because of its ability to adapt to a wide range of
temperatures. P. aeruginosa also has the ability to grow in poor nutrient environments. Water treatments
remove most microbial contamination from the water but P. aeruginosa problems remain in large
buildings such as hospitals. Issues with P. aeruginosa arise because the plumbing installation allows the
bacteria to proliferate and form a biofilm. This is seen in the areas of the plumbing where there are high
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levels of nutrients for bacteria such as infrequently used outlets. P. aeruginosa growth is best seen near
the distal ends of the plumbing like the sink because of the aerobic conditions (Loveday et al 2013).

P. aeruginosa infection is a serious healthcare issue as not only it can grow aerobically, but it also has the
ability to grow in the microaerobic and anaerobic environment. One major example is the chronic lung
infection in cystic fibrosis. With cystic fibrosis, P. aeruginosa is the dominant pathogen that cannot be
treated with antibiotics. P. aeruginosa has the ability to adapt to different conditions because of its
complex enzyme system. The enzyme systems are used to generate enzymes needed under oxygenrestricted or anaerobic conditions. Because of the heterogeneous environment of the cystic fibrosis
produced by the mucus in the lungs, P. aeruginosa has the ability to produce enzymes for microaerobic
growth, de-nitrification, and fermentation. The stress response system and universal stress proteins
produced by the P. aeruginosa allow the bacteria to survive during anaerobic energy starvation conditions
(Schobert and Jahn 2010).

When P. aeruginosa is grown under hypoxic conditions, causing the stress proteins secretion,
physiological changes occur such as alterations to the outer membrane. These alterations can lead to
increased tolerance to antibiotics (Schobert and Jahn 2010). Because the bacterium is gram-negative, it
has an outer membrane, lipopolysaccharide (LPS), which protects it from the outside environment. The
membrane also works as a sieve using specific and general pre-forming proteins. The pores allow for
small molecules to cross the membrane, but larger molecules that are needed to be transported as well.
Many known soluble exoproteins are secreted from P. aeruginosa. Of these exoproteins, most of them
are virulence factors. P. aeruginosa is also known as one of the most actively secreting gram-negative
bacteria (Bitter 2003). In addition to the chaperone/usher pathway, there are five more protein secretion
systems including Type I (T1SS), II (T2SS), III (T3SS), IV (T4SS) and V (T5SS) secretion systems in
Gram-negative bacteria. An example of the complexity of the protein secretion system was observed in
the Type III secretion system (T3SS). P. aeruginosa can have one of more of the four genes with encode
2

for four cytotoxins. The cytotoxins being produced can lead to migration of the bacteria from the site of
infection and inhibition of host cell DNA synthesis (Jabalameli et al 2012). Another example of the
cytotoxins being produced is seen in the production of autotransporters mainly by P. fluorescens. This
autotransporter PfaI is a part of the type V protein secretion system (T5SS). This system is unique
because it has all of the components necessary for protein translocation within a single polypeptide. PfaI
also has a virulence factor involved in the interaction with the host cell and modulating the immune
response (Hu et al 2009). Along with the cytotoxins being produces, P. aeruginosa produces
biosurfactants. One of the most studied biosurfactants is rhamnolipids produced by P. aeruginosa.
Rhamnolipids have potential industry and environmental applications because the antimicrobial properties
(Samadi et al 2012). Pseudomonas has the ability to produce the gamma-aminobutyric acid (GABA) and
the GABA-binding proteins. In the presence of GABA, P. fluorescens does not produce the
biosurfactants (Dagorn et al 2013). Pseudomonas also produces extracellular proteases which typically
help to provide nutrient for the bacteria by hydrolyzing large proteins. The proteases can also play a role
in plant pathogenesis (Anderson et al 2004).

Along with the cases previously mentioned, P. aeruginosa is the source of many other infections
including urinary tract infections, upper and lower respiratory tract infections, and bloodstream infection
(Lavoie et al 2011). P. aeruginosa is also a major pathogen in infections of burn patients (Jabalameli et al
2012). There are certain innate immune responses that primarily control P. aeruginosa. These responses
are very important to recognize and clear the pathogen. In respiratory tract infections, this has to be done
while maintaining minimum inflammation-mediated damage. P. aeruginosa has the ability to alter the
host immune response after infection. It also has many variability factors that affect the host immune
response to the bacteria. In the mammalian respiratory tract, the bacteria have the ability to change the
expression and structure of ligands that normally are known to be immutable. These changes cause the
innate immune response to the P. aeruginosa to vary (Lavoie et al 2011). The acquired differences were
seen in a study observing the difference between P. aeruginosa from an infected wound and an isolated
3

colony (Ramos et al 2008). The variability was also seen in P. fluorescens with its ability to change its
metabolism to adjust to the dangers of toxic compounds. To combat oxidative stress, P. fluorescens
decreases the formation of the pro-oxidant NADH and increase in the anti-oxidant NADPH (Mailloux et
al 2011).

Bacteria have different abilities to adapt to rapid changes of environmental conditions (Baumgarten et al
2012). In addition to the metabolic effects of Pseudomonas, the genus of bacteria is notoriously harmful
because of its ability to grow a biofilm. Biofilm is the accumulation of the microorganism in an
exopolysaccharide matrix. P. aeruginosa biofilm is usually present in infections in acute burn wounds.
Because of this biofilm formation, the survival rate in hostile environments increases. Biofilm formation
protects the bacteria from the host immune response (Jabalameli et al 2012) so the immune response
cannot eradicate the biofilm (Alhede 2014). The growth of this biofilm leads to a more persistent
infection. It also increases the bacteria’s tolerance to antibiotics by creating a physical barrier to the host
defense system (Schobert and Jahn 2010). Biofilm formation can promote horizontal gene transfer. This
can lead to genetic diversity (Ramos et al 2010). Biofilm formation can also lead to sharing of metabolic
by-products within the biofilm community (Baumgarten et al 2012).

The physical barrier created by Pseudomonas becomes problematic because it has a reduced susceptibility
to antimicrobial agents. The formation of a biofilm occurs by coordinating different cells to participate in
certain surface-association behaviors. The formation occurs in a five-stage process including (1) Initial
attachment, (2) Irreversible attachment, (3) Maturation I, (4) Maturation II and (5) Dispersion (Sauer et al
2002). The cells first enter a transitional state of reversible surface attachment, which must be stabilized
for biofilm formation. As the biofilm matures, it forms microcolonies and macrocolonies. These colonies
are encased in an extracellular matrix. This matrix is to organize and structure the bacteria community.
The biofilm matrix consists of proteinaceous material, membrane vesicles, DNA, and exopolysaccharides
(Merritt et al 2007). Biofilm formation is in part regulated by flagellum-based motility. The two4

component system SadC/B influences motility and biofilm formation. Mutations in flagellar regulation or
biogenesis in Pseudomonas effects the formation of the biofilm (Mastropaolo et al 2012).

Biofilm formation plays a major role in Pseudomonas infections in a clinical setting. Patients with cystic
fibrosis and chronic P. aeruginosa infections show biofilm formation in the conductive airways within the
mucus in the lungs. Patients with diabetes and cardiovascular disease are showing an increase in chronic
wounds. The intense accumulation of biofilm found in cystic fibrosis patients is also seen in chronic
wounds. Another location of the intense accumulation of biofilm is in otitis media in the middle ear.
Biofilm formation is detrimental in healthcare because of medical device related infections. These
infections may occur from contamination from a patient’s skin or mucous membrane. The infection can
also occur from the surgical or clinical staff. P. aeruginosa biofilm infections are almost unavoidable in
prolonged catheterization (Alhede et al 2014).

There have been many approaches to inhibit growth of this dangerous Pseudomonas genus. A novel
approach would be to use natural products. Of the drugs in clinical use, approximately half of them are
derived natural products. Even though this statistic is fairly high, chemists do not usually embrace the use
of natural products. A major downfall of the natural products is the compounds are usually found in small
quantities in comparison to synthesized compounds. This leads to the need for drugs with a greater
quality than quantity. Many treatments, such as cancer chemotherapy, are ideal opportunities for natural
product. Natural products are beneficial in comparison to artificially designed molecules because they
naturally have a high specify and potency. Natural products also have well defined three dimensional
structures with many functional groups. The targets of the natural products are well conserved
(Paterson and Anderson 2005).

One major group of natural products is commonly seen in herb and spices called essential oils. The
essential oils of thyme, oregano, clove, and cinnamon have been shown to have strong antimicrobial
5

effects. The complexity and synergy of essential oils make them very useful against multidrug resistant
bacterial strains such as Pseudomonas (Sienkiewicz et al 2012). The use of essential oils is seen in
mouthwash. The active ingredients in commercial mouthwashes are menthol, eucalyptol, thymol, and
methyl salicylate (Erriu et al 2013). The use of natural products is also seen in other extracts from various
microbes. Crude extracts from endophylic fungi of mangrove plants were analyzed for antimicrobial
activity. It was found that the extracts had an antimicrobial effect over a wide range of bacteria, including
Pseudomonas (Buatong et al 2011).

In this study, a variety of natural products were studied to observe any antimicrobial effect. One of the
products used was theaflavin. Theaflavin is a type of polyphenol found in black tea extract. The formation
of theaflavins occurs after the fermentation of monomeric flavan-3-ols. This leads to the production of
theaflavins along with other oligomers. Theaflavins and its oligomers normally consist of 1-2% of the
total dry matter in tea. In this study, the powder was 20% theaflavin. Many studies have been performed
to observe the properties and structure of theaflavin and the oligomers (Figure 1). More recently, the
pharmacological functions have been studied (Vermeer et al 2008).

The next polyphenol used in this study was Fallopia multiflora (Polygonum multiflorum). This tuberous
root is also known as Chinese Knotweed (Figure 2). Chinese Knotweed grows in Guangxi, Henan, and
Guizhou (Wang et al 2010). Chinese Knotweed is known as a tonic and anti-aging agent in traditional
Chinese medicine. The herb also has a protective effect on the cardiovascular system (Liu et al 2010).
Other tradition uses include nerve injury, constipation, and premature white hair (Wang et al 2010).
Figure 3 showed the major constituents of the herb include emodin, rhein, other phenolic compounds and
their glycosides (Yao et al 2006).
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Theaflavin (TF1)

Theaflavin-3-Gallate and Theaflavin-3’-Gallate (TF2a and TF2b)

Theaflavin-3-3’-digallate (TF3)

Figure 1: Molecular structure of major Theaflavins (TF1, TF2 & TF3) found in black tea.
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Figure 2: Fallopia multiflora root.

Figure 3: Active components of Fallopia multiflora root.
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The next natural product studied were two polymethoxyflavones (PMFs) (Figure 4), a subgroup of
flavonoids, and two derivatives. Aside from black tea, flavonoids are present in fruits, vegetables, nuts,
and seeds. About 800 varieties of flavonoids have been identified (Mohan and Nandhakumar 2013).
Flavonoids are polyphenol compounds involved in plant secondary metabolite processing. Flavonoids
have the ability to modulate protein kinases. They also modulate epidermal growth factor receptors,
cyclin-dependent kinases, vascular endothelial growth factor receptors, and platelet derived growth factor
receptors. Flavonoids also have the ability to inhibit multiple enzymes involved in inflammation and
cancer pathology (Ravishankar et al 2013). Nobiletin and tangeretin are PMFs derived from orange and
tangerine peel. PMFs play a role in numerous biological functions. They also have neuroprotective,
anticancer, and antimetastatic properties. More recent studies show that nobiletin and tangeretin can
modulate adipocytokine secretion balance leading to treatment of insulin resistance (Miyata et al 2011).
Antimicrobial effects of nobiletin and tangeretin against Pseudomonas have been previously studied at
3.6 mg/mL (Yao et al 2011). This is why derivatives of the two products were also studied. Structural
modifications can be acquired by adding a functional group or using genetic engineering to reconstruct
the pathways. In this study, the derivatives of nobiletin and tangeretin had an addition 5’-hydroxyl group.
A new alternative in medicine is using combinational chemistry and diversity goaled synthesis. This
offers a range of structural differences that are based on a common core. This provides a larger screening
library in a shorter amount of time (Paterson and Anderson 2005).
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Figure 4: Molecular structure of the polymethoxyflavones nobiletin (A) and tangeretin (B).
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A sulfated polysaccharide extracted from red microalgae Porphyridium was used to observe any
antimicrobial effects. The red microalgae used were a habitat was fresh water, sea water, and brackish
water. The red microalgae were cultivated in a large scale algae cultures (Figure 5). This improved the
light availability by increasing the surface volume ratio. The red microalgae were encapsulated with
sulfated polysaccharide (Figure 6). The polysaccharide was sulfated at the bioactive groups. These
polysaccharides are believed to have a wide range of uses. The uses include antibacterial, antifungal, and
anti-inflammatory. The sulfated polysaccharide has shown antiviral effects against herpes simplex virus 1
and 2. It also has shown antiviral effects against a variety of other viruses (Huheihel et al 2001). The
polysaccharide also has a buffer layer to protect against extreme environments such as temperature, pH,
and salinity. The polysaccharides in the cell wall have different compositions, but similar functions
(Geresh and Arad 1991).

In this study, the mentioned seven natural products were used to observe any antimicrobial effects on the
very harmful bacteria Pseudomonas. Biofilm inhibitory effects by natural products were also determined.
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Figure 5: Large scale cultivation of red microalgae Porphyridium.

Figure 6: Proposed structure of the polysaccharide extracted from the microalgae species Porphyridium.
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Materials and Methods
Bacterial culture
P. aeruginosa and P. fluorescens were obtained from Carolina Biological Supply Company. The
bacteria were cultured using Difco™ LB Broth (LB), Difco™ Tryptic Soy Broth (TSB), and
Carolina Nutrient Broth (NB) dehydrated media. The bacteria was cultured at 37o C and
constantly shaken at 250 rpm.

Preparation of compound solutions
The red algae polysaccharide was obtained from Dr. Shoshana Arad of the Institutes of Applied
Research at Ben-Gurion University of the Negev in Be’er-Sheva, Israel. Because of its high
viscosity, the polysaccharide was diluted to 1% using diH2O. The pure flavonoids tangeretin and
nobiletin, as well as their derivatives, were received from the laboratory of Dr. Chih-Yu Lo of
National Chiayi University in Chiayi, Taiwan. 3mM stock solutions were made by dissolving
the compounds in DMSO. The solutions were then filtered using Acrodisc® 13 mm sterilized
syringe filters with 0.2 µm Supor® membranes. The black tea polyphenol was purchased from
Jiangyin Dehe Biotechnology Company in Edison, NJ. The 20% theaflavin powder was
dissolved in DMSO to prepare a 5% stock solution. The solutions were then filtered using
Acrodisc® 13 mm sterilized syringe filters with 0.2 µm Supor® membranes. The Fallopia
multiflora (Chinese Knotweed) was obtained from Dr. Lo as well. All compounds were stored at
4oC. For the experiments, a vehicle control was used to observe any toxic effects of the solvents.
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Table 1: Complete list of the natural products used as potential anti-Pseudomonas agents.
Natural Product

Stock Concentration

Working Concentration

Theaflavin

5%

5%

Chinese Knotweed

5%

5%

Polysaccharide

5%

1%

Nobiletin

3 mM

1 mM

Tangeretin

3 mM

1 mM

5'OH-Nobiletin

3 mM

1 mM

5'OH-Tangeretin

3 mM

1 mM

Microtiter plate antimicrobial inhibition assay
A microtiter plate assay was used to observe any antimicrobial effects of the natural compounds
using P. fluorescens. The P. fluorescens was inoculated in a 5-7 mL culture overnight to grow to
stationary phase. The appropriate amount of NB or LB was added to the wells in a clear Corning
96-well microtiter plate so that each well had a total volume of 120 µL. The desired
concentration of the natural product was then added to the well. The same amount of P.
fluorescens (5 µL) was added to the wells. The growth of the bacteria in the presence and
absence of the natural products was then observed. The growth was monitored over a 24-hour
period obtaining the OD600 at 0, 1, 2, 3, 4, 5, 6, 7, 8, 12, and 24 hours. The absorbance was
measured at 600 nm wavelength using a SpectraMax M5 from Molecular Devices. Over the 24
hours, the microtiter plate was maintained at 37o C and constantly shaken at 250 rpm. Any
antimicrobial effects of the natural product were then observed.
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Culture tube antimicrobial inhibition assay
A culture tube assay was used to observe any antimicrobial effects of the natural compounds
using P. aeruginosa. The P. aeruginosa was inoculated in a 5-7 mL culture overnight to grow to
stationary phase. The appropriate amount of NB or LB was added to the VWR 17x100 mm
culture tubes with closures so that each tube had a total volume of 6 mL. The desired
concentration of the natural product was then added to the culture tubes. The same amount of P.
aeruginosa (250 µL) was added to the culture tubes. The growth of the bacteria in the presence
and absence of the natural products was then observed. The growth was monitored over a 24hour period obtaining the OD600 at 0, 1, 2, 3, 4, 5, 6, 7, 8, 12, and 24 hours. Using proper aseptic
technique, 1mL of the bacteria culture was removed to gather the absorbance using a Pharmacia
LKB Ultraspec III and returned to the culture tube. Over the 24 hours, the culture tubes were
maintained at 37oC and constantly shaken at 250 rpm. Any antimicrobial effects of the natural
product were then observed.

Biofilm inhibition using crystal violet assay
A crystal violet assay was performed to observe any biofilm inhibition properties of the natural
products. The P. aeruginosa and P. fluorescens were inoculated in a 5-7 mL culture overnight to
grow to stationary phase. The appropriate amount TSB was added to the non-treated Cellstar®
24-well suspension culture plate so that the total volume was 2 mL. The desired treatment
concentration of the natural product was then added to the appropriate well. The bacteria were
grown to stationary phase (OD600=~1) was then diluted to 1:5 using TSB, and 1mL of the diluted
bacteria was added to the wells. The plates were then covered and incubated at 37o C and 250
rpm for 5 days. After the incubation period, a crystal violet staining was performed. Four small
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trays were set up in a series adding 1-2 inches of tap water to the last three. The planktonic
bacteria were removed by shaking it over the first dish. The plate was then submerged in the
first water tray to wash the wells. Two hundred microliters of a 0.1% crystal violet/water
solution was then added to each well. The plates were incubated at room temperature for 10
minutes to stain the biofilm. The crystal violet solution was then removed by shaking it over the
waste tray. The plates were then washed in the remaining 2 trays. As much liquid as possible
was removed after each wash. After the washes, the plate was inverted and tapped on paper
towels to remove excess liquid. The plate was then allowed to air dry. The dye was solubilized
by adding 500 µL of 95% ethanol. The plate was incubated at room temperature for 10 minutes.
The mixture was resuspended using a pipette. The absorbance was then read at 570 nm
wavelength.

Microscopic observation of biofilms
A crystal violet assay with cover slips was performed to visualize any biofilm inhibition
properties of the natural products. The P. aeruginosa and P. fluorescens were inoculated in a 5-7
mL culture overnight to grow to stationary phase. The non-treated Cellstar® 24-well suspension
culture plate was prepared by adding 500 µL of TSA and allowing it to solidify. A glass
microscope cover slip (12 mm) was then added to the agar in each well at a 90o angle. The
appropriate amount TSB was added to the culture plate so that the total liquid volume was 1.5
mL. The desired treatment concentration of the natural product was then added to the
appropriate well. The bacteria grown to stationary phase (OD600=~1) was then diluted to 1:5
using TSB, and 1 mL was added to the wells. The plates were then covered and incubated at
37oC and 250 rpm for 5 days. After the incubation period, a crystal violet staining was
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performed on the cover slips. The cover slips were carefully removed from the wells. A sterile
pipette was used to add 3-4 drops of a 0.1% crystal violet/water solution to the cover slip. The
cover slip was incubated at room temperature for 10 minutes. At the end of the incubation, the
cover slip was washed by adding drops of diH2O using a sterile pipette. The cover slip was then
allowed to air dry. Images were then obtained of the cover slip using the bright field on an
Olympus Fluoview FV1000 microscope.

Statistical Analysis
Each experiment was performed in triplicate. The p value was obtained to determine the
statistical significance (p<0.05) using student’s t-test. Standard deviation error bars were added
to the growth curves.
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Results
Antimicrobial Inhibition Assay
Antimicrobial effects of the seven natural products on P. fluorescens and P. aeruginosa were
determined. The growth curves of the bacteria were monitored by turbidity study at 600 nm
wavelength. The percent inhibition of the natural products on the bacteria was also determined.
The first graph for each compound shows the growth monitoring, followed by the percentage of
inhibition. The percentages reported are from the 8 hour time point because this is the time point
the bacteria were found to reach stationary phase.

1. Theaflavin
The concentration of P. fluorescens treated with the theaflavin compared to the untreated
bacteria was lower, and demonstrated the antimicrobial effect of theaflavin. P. fluorescens
treated with 2.5% theaflavin showed completely inhibition of growth. P. fluorescens treated
with 1.25% theaflavin showed the growth was reduced by half of the control. P. fluorescens
treated with 0.625% theaflavin showed slight inhibitory effect. There was a statistically
significant difference (p<0.05) between the control and treated group (with 2.5% TF) from the
second hour and on (Figure 7). P. fluorescens treated with 2.5% theaflavin showed 90.89%
growth inhibition. P. fluorescens treated with 1.25% theaflavin showed 50.24% growth
inhibition. P. fluorescens treated with 0.625% theaflavin showed 28.37% growth inhibition
(Figure 8).
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Figure 7: Growth curve of Pseudomonas fluorescens treated with theaflavin. * indicates
statistically significant.

Figure 8: Percent inhibition of Pseudomonas fluorescens treated with theaflavin.
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The concentration of P. aeruginosa treated with the theaflavin compared to the bacteria not
treated was lower and demonstrated the antimicrobial effect of theaflavin. P. aeruginosa treated
with 2.5% theaflavin showed the growth was completely inhibited. P. aeruginosa treated with
1.25% theaflavin showed strong inhibition of growth, but not to the effect as 2.5% theaflavin.
There was a statistically significant difference (p<0.05) between control and treatment group
(1.25% TF) since the third hour and 2.5% TF from the second hour and on (Figure 9). P.
aeruginosa treated with 2.5% theaflavin showed 82.76% growth inhibition. P. aeruginosa
treated with 1.25% theaflavin showed 67.14% growth inhibition (Figure 10).
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Figure 9: Growth curve of Pseudomonas aeruginosa treated with theaflavin. * indicates
statistically significant.

Figure 10: Percent inhibition of Pseudomonas aeruginosa treated with theaflavin.
21

2. Chinese Knotweed
The concentration of P. fluorescens treated with the Chinese knotweed compared to the untreated
bacteria was lower and demonstrates the Chinese knotweed antimicrobial effect. P. fluorescens
treated with 2.5% and 1.25% Chinese knotweed showed completely inhibition of its growth. P.
fluorescens treated with 0.625% Chinese knotweed showed some inhibitory effect on the growth.
The difference between control group and the treatment groups (all three concentrations: 2.5%,
1.25% and 0.625%) are statistically significant (p<0.05) from the third hour (Figure 11). P.
fluorescens treated with 2.5% Chinese knotweed showed 97.54% growth inhibition. P.
fluorescens treated with 1.25% Chinese knotweed showed 94.95% growth inhibition. P.
fluorescens treated with 0.6% Chinese knotweed showed 63.91% growth inhibition (Figure 12).
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Figure 11: Growth curve of Pseudomonas fluorescens treated with Chinese Knotweed. *
indicates statistically significant.

Figure 12: Percent inhibition of Pseudomonas fluorescens treated with Chinese knotweed.
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3. Red Algae Polysaccharide
The concentration of P. fluorescens treated with the red algae polysaccharide compared to the
bacteria not treated was lower demonstrating the polysaccharides antimicrobial effect. P.
fluorescens treated with 1.0% polysaccharide showed completely inhibition of growth. P.
fluorescens treated with 0.5% polysaccharide showed slight inhibition of its growth. P.
fluorescens treated with 0.1% polysaccharide showed very little inhibitory effect. For
polysaccharide, 0.5% showed statistically significant difference (p<0.05) when compared with
control (Figure 13). P. fluorescens treated with 1% of the red algae polysaccharide showed
75.09% growth inhibition. P. fluorescens treated with 0.5% of the polysaccharide showed
12.66% growth inhibition (Figure 14).
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Figure 13: Growth curve of P. fluorescens treated with the red microalgae polysaccharide. *
indicates statistically significant.

Figure 14: Percent inhibition of P. fluorescens treated with the red microalgae polysaccharide
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4. Nobiletin
The concentration of P. fluorescens treated with the nobiletin compared to the bacteria not
treated was lower demonstrating the nobiletin antimicrobial effect. P. fluorescens treated with
500 µM nobiletin showed completely inhibition of growth. P. fluorescens treated with 250 µM
nobiletin showed 63% inhibition. P. fluorescens treated with 125 µM nobiletin showed little
inhibition or the growth was slightly inhibited. The bacteria treated with 500 µM nobiletin were
shown almost complete inhibition from the second hour with statistically significant difference
(p<0.05) while 250 µM nobiletin showed significant inhibition (p<0.05) from the third hour and
on compared with the control (Figure 15). P. fluorescens treated with 500 µM nobiletin showed
87.18% growth inhibition. P. fluorescens treated with 250 µM nobiletin showed 62.90% growth
inhibition. P. fluorescens treated with 125 µM nobiletin showed 32.04% growth inhibition
(Figure 16).
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Figure 15: Growth curve of Pseudomonas fluorescens treated with nobiletin. * indicates
statistically significant.

Figure 16: Percent inhibition of Pseudomonas fluorescens treated with nobiletin.
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5. Tangeretin
The concentration of P. fluorescens treated with the tangeretin compared to the bacteria not
treated was lower demonstrating the tangeretin antimicrobial effect. P. fluorescens treated with
500 µM tangeretin showed completely inhibition of its growth. P. fluorescens treated with 250
µM tangeretin showed inhibition of growth by half. P. fluorescens treated with 125 µM
tangeretin showed little inhibition of growth. Both 250 and 500 µM tangeretin showed
statistically significant difference (p<0.05) compared with control groups (Figure 17). P.
fluorescens treated with 500 µM tangeretin showed 91.80% growth inhibition. P. fluorescens
treated with 250 µM tangeretin showed 53.66% growth inhibition. P. fluorescens treated with
125 µM tangeretin showed 24.63% growth inhibition (Figure 18).
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Figure 17: Growth curve of Pseudomonas fluorescens treated with tangeretin. * indicates
statistically significant.
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Figure 18: Percent inhibition of Pseudomonas fluorescens treated with tangeretin.
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12

6. 5’OH-nobiletin
The concentration of P. fluorescens treated with the 5’OH-nobiletin compared to the bacteria not
treated was lower demonstrating the 5’OH-nobiletin antimicrobial effect. P. fluorescens treated
with 500 µM 5’OH-nobiletin showed highest inhibition (p<0.05). P. fluorescens treated with
250 µM 5’OH-nobiletin showed the growth was inhibited severely. P. fluorescens treated with
125 µM 5’OH-nobiletin showed little inhibition of growth (Figure 19). P. fluorescens treated
with 500 µM 5’OH-nobiletin showed 85.27% growth inhibition. P. fluorescens treated with 250
µM 5’OH-nobiletin showed 42.92% growth inhibition. P. fluorescens treated with 125 µM
5’OH-nobiletin showed 18.67% growth inhibition (Figure 20).
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Figure 19: Growth curve of Pseudomonas fluorescens treated with 5’-OH nobiletin. * indicates
statistically significant.

Figure 20: Percent inhibition of Pseudomonas fluorescens treated with 5’-OH nobiletin.
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7. 5’OH-tangeretin
The concentration of P. fluorescens treated with the 5’OH-tangeretin compared to the bacteria
not treated was lower demonstrating the 5’OH-tangeretin antimicrobial effect. P. fluorescens
treated with 500 µM 5’OH-tangeretin the growth was completely inhibited from the third hour
and on (p<0.05). P. fluorescens treated with 250 µM 5’OH-tangeretin showed the growth
severely inhibited. P. fluorescens treated with 125 µM 5’OH-tangeretin showed little inhibition
of growth (Figure 21). P. fluorescens treated with 500 µM 5’OH-tangeretin showed 87.64%
growth inhibition. P. fluorescens treated with 250 µM 5’OH-tangeretin showed 47.37% growth
inhibition. P. fluorescens treated with 125 µM 5’OH-tangeretin showed 25.40% growth
inhibition (Figure 22).
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Figure 21: Growth curve of Pseudomonas fluorescens treated with 5’OH-tangeretin. * indicates
statistically significant.

Figure 22: Percent inhibition of Pseudomonas fluorescens treated with 5’OH-tangeretin.
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The percent inhibition of P. fluorescens treated with the natural products at the highest
concentration was observed at the 8 hour time point (Figure 23). At 8 hours the bacteria reached
stationary phase. The noteworthy antimicrobial effects with a growth inhibition above 50% were
compiled to compare the effects on Pseudomonas (Table 2).
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Figure 23: Percent inhibition at 8 hours of P. fluorescens treated with all seven natural products.
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Table 2: Summary of the antimicrobial effects of natural products on Pseudomonas fluorescens.
Natural Product

Percent Inhibition

Concentration

50.24%

1.25%

90.89%

2.50%

67.14%

1.25%

82.76%

2.50%

63.91%

0.625%

94.95%

1.25%

97.54%

2.50%

75.09%

0.5%

62.90%

250µM

87.18%

500µM

53.66%

250µM

91.8%

500µM

5'OH-Nobiletin

85.27%

500µM

5'OH-Tangeretin

87.64%

500µM

Theaflavin (P. flu)
Theaflavin (P. aeru)

Chinese Knotweed
Red Microalgae Polysaccharide
Nobiletin
Tangeretin
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Microscopic Observations
The antimicrobial effects of the natural products on P. aeruginosa were observed using the
bright field on an Olympus Fluoview FV1000 microscope. The images were analyzed looked at
characteristics such as morphology and cell population (Figure 24-30). P. aeruginosa treated
with the theaflavin showed a lower cell population in comparison to the untreated bacteria. The
morphology of the bacteria also appeared to be elongated. P. aeruginosa treated with the Chinese
knotweed did not show a morphology change, however the cell population was greatly reduced.
P. aeruginosa treated with the polysaccharide show a slightly lower cell population. P.
aeruginosa treated with tangeretin showed a lower cell population in comparison to the
untreated. The morphology of the bacteria appeared more elongated. P. aeruginosa treated with
nobiletin showed a lower cell population in comparison to the untreated. The morphology of the
bacteria appeared more elongated. P. aeruginosa treated with 5’OH-tangeretin showed a slightly
lower cell population in comparison to the untreated. The morphology of the bacteria appeared
to be a mixture of the wild type and elongated cells. P. aeruginosa treated with 5’OH-nobiletin
showed a lower cell population in comparison to the untreated. The morphology of the bacteria
appeared more elongated. All images are shown in a total magnification of 600X.
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10 µm

10 µm

Figure 24: Pseudomonas aeruginosa untreated (A) and treated with 2.5% theaflavin (B).

10 µm

10 µm

Figure 25: Pseudomonas aeruginosa untreated (A) and treated with 2.5% Chinese Knotweed
(B).
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10 µm

10 µm

Figure 26: Pseudomonas aeruginosa untreated (A) and treated with the 0.5% red microalgae
polysaccharide (B).

10 µm

10 µm

Figure 27: Pseudomonas aeruginosa untreated (A) and treated with 500 µM nobiletin (B).
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10 µm

10 µm

Figure 28: Pseudomonas aeruginosa untreated (A) and treated with 500 µM tangeretin (B).

10 µm

10 µm

Figure 29: Pseudomonas aeruginosa untreated (A) and treated with 500 µM 5’OH-nobiletin (B).
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10 µm

10 µm

Figure 30: Pseudomonas aeruginosa untreated (A) and treated with 500 µM 5’OH-tangeretin
(B).
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Biofilm Inhibition Assay
The inhibitory effects of the natural products on the biofilm formation of P. fluorescens and P.
aeruginosa were observed. A crystal violet assay was performed on the 24-well plate to detect
the biofilm and obtain visual and quantitative results. The absorbance at 570nm was used to
quantitatively analyze biofilm. P. fluorescens treated with both 1.25% and 2.5% theaflavin
showed a lower amount of biofilm present demonstrating biofilm inhibition. Each concentration
had a p<0.05 meaning there was a statistically significant difference among the groups (Figure
31). P. fluorescens treated with 2.5% theaflavin inhibited biofilm formation by 70.57%. P.
fluorescens treated with 1.25% theaflavin inhibited biofilm formation by 62.61%. P. aeruginosa
treated with two different concentrations of theaflavin demonstrated a very strong biofilm
inhibition. . Each concentration had a p<0.05 meaning there was a statistically significant
difference among the groups (Figure 33). P. aeruginosa treated with 2.5% theaflavin inhibited
biofilm formation by 97.72%. P. aeruginosa treated with 1.25% theaflavin inhibited biofilm
formation by 97.50% (Figure 34).
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Figure 31: Crystal violet assay of Pseudomonas fluorescens biofilm treated with theaflavin.

Figure 32: Biofilm inhibition of Pseudomonas fluorescens treated with theaflavin.
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Figure 33: Crystal violet assay of Pseudomonas aeruginosa biofilm treated with theaflavin.

Figure 34: Biofilm inhibition of Pseudomonas aeruginosa treated with theaflavin.
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The inhibitory effects of theaflavin on the biofilm formation of P. aeruginosa were observed by
using microscopic analysis. An example of the experimental setup is shown in Figure 35. A
simple stain with methylene blue was performed on the bacteria biofilm grown on a cover slip
and the images were obtained by using the bright field on an Olympus Fluoview FV1000
microscope. P. aeruginosa treated with theaflavin showed a lower amount of biofilm present
demonstrating biofilm inhibition (Figure 36).
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Figure 35: Pseudomonas aeruginosa biofilm formation experimental setup. (Top) The 24-well
plate with glass cover slip positioned perpendicular to the bottom of the well in each well.
(Bottom) The coverslips were removed and stained with methylene blue for microscopic
observations under total magnification of 600X.
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B

A

C

10 µm

10 µm

10 µm

Figure 36: Microscope images of Pseudomonas aeruginosa biofilm untreated (A) and treated
with 1.25% (B) and 2.5% (C) of theaflavin using a cover slip.
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Conclusions and Discussion
In this study, seven natural products were studied to observe the antimicrobial effects on the
harmful Pseudomonas. The biofilm inhibitory effects were also observed. The products
included polyphenolic compounds found in black tea theaflavins, tuberous root Fallopia
multiform (Chinese Knotweed), polysaccharide found in red microalgae, flavonoids found in
citrus pith and peels: nobiletin, tangeretin, and their derivatives, 5’OH-nobiletin and 5’OHtangeretin.

The results from antimicrobial assays showed that all selected natural products contain antiPseudomonas activities as the bacterial growth was severely (if not completely) inhibited. The
top three natural products, theaflavins, Chinese Knotweed and Tangeretin, displayed a growth
inhibition above 90%. P. fluorescens treated with 2.5% theaflavin showed 90.89% growth
inhibition. P. fluorescens treated with 2.5% Chinese knotweed showed 97.54% growth
inhibition. P. fluorescens treated with 1.25% Chinese knotweed showed 94.95% growth
inhibition. P. fluorescens treated with 500 µM tangeretin showed 91.80% growth inhibition.
This is very interesting because theaflavin and Chinese Knotweed are both polyphenols. From
findings, it may be significant to explore the antimicrobial effects of other phenolic constituents
in the flavones. Fallopia multiform (Chinese Knotweed) showed the greatest effect as it
completely inhibited Pseudomonas growth at both 2.5% and 1.25%. The results encourage us to
investigate more natural products used in traditional Chinese medicine. From the microscopic
observations, the bacteria population significantly reduced when treated with the compounds in
comparison to the control. This correlates with the results obtained from other assays shown
above.
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Biofilm formation has been significantly reduced or completely inhibited when the bacteria were
treated with the natural compounds. Theaflavin showed a greater biofilm inhibition in P.
aeruginosa than in P. fluorescens treated with the theaflavin. Microscopic observations of the
biofilms confirmed the results. The biofilm was clearly present for untreated bacteria. With
2.5% theaflavin, P. fluorescens showed significant biofilm reduction while P. aeruginosa
showed no biofilm with a few isolated cells remained. This suggests that theaflavin and other
polyphenols may serve as potential anti-Pseudomonas biofilm agent.

The infections of gram-negative bacteria Pseudomonas has been an ongoing problem in
healthcare, especially in the intensive care unit. This study provides an initial profile for several
different types of natural products that could be good antibacterial agents for Pseudomonas and
its biofilms. The synergistic antibacterial activity of natural products and antiseptics should be
explored so we may be able to find a natural way to eradicate Pseudomonas infection. The
results also lead to the need for the discovery of the anti-Pseudomonas mechanism of the natural
products. The natural products should be tested on other biofilm forming bacteria. We should
also explore the possibilities of using the natural products in therapeutic application. To perform
this, the natural products should be used on mammalian cells.
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